Navigation Links
Dovel Technologies Awarded Biologics Surveillance IDIQ
Date:10/25/2018

Dovel Technologies announced today they have been awarded two IDIQs from the Food and Drug Administration (FDA) Center for Biologics Effectiveness and Research (CBER) for the CBER Biologics Effectiveness and Safety (BEST) Initiative. The program will help CBER expand and enhance current capabilities with respect to data sources, infrastructure, methods, and tools and to conduct active surveillance, epidemiologic studies and automated reporting to improve the the safety and efficacy of biologic products including vaccines, blood and blood products, tissues, and advanced therapeutics.

“We are excited to get to work helping build the data strategy and tools that will enhance CBER’s efficiency in meeting their mission to assure the safety and efficacy of biologic products,” said Dovel COO, Damon Griggs. “Our team has exciting and innovative approaches and solutions for data science and automation using machine learning, natural language processing, and more to meet the needs of CBER.”

Dovel has been awarded two separate IDIQs; Data, Tools and Infrastructure for Surveillance of Biologics as well as Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Biological Products.

Dovel secured one of four awards for each of these five-year IDIQs. Each award has a ceiling of $75 million. Dovel is supported by a collaborative team that brings significant breadth and depth including access to leading national data sources of claims and EHR data, biostatistics and epidemiology as well as expertise in machine learning, natural language processing and Artificial Intelligence.

The awards expand Dovel’s work with CBER. The company has been supporting the agency’s Laboratory Information Management System (LIMS) development, integration, and deployments since 2011.

About Dovel Technologies
Dovel advances the mission of its customers in health, life sciences, and grants management through the integration of technology and domain expertise and delivers complex systems integration and information management technology solutions for highly complex and data-driven environments. To learn more visit http://www.doveltech.com.

Contact:
Piper Conrad
piper.conrad@gmail.com
571-499-3718

Read the full story at https://www.prweb.com/releases/dovel_technologies_awarded_biologics_surveillance_idiq/prweb15863433.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. NREL staff recognized for breakthrough technologies
2. Evonik Industries Selects OPX Biotechnologies for Joint Development of Bio-Based Chemicals
3. PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace
4. Join Leading Organizations at Biodetection Technologies 2013 in Alexandria, VA from June 18-19, 2013
5. Bioinspired and Nanoengineered Surfaces: Technologies, Applications and Global Markets
6. New technologies and ingredients provide better options for gluten-free eating
7. LaserLock Technologies Moves Forward With An Even More Secure Multi-Factor Internet/Mobile Login System
8. Geoscientists unearth mineral-making secrets potentially useful for new technologies
9. Butterfly wings inspire new technologies: from fabrics and cosmetics to sensors
10. LaserLock Technologies Files A New Provisional Patent Which Secures Player Identity On Internet Gaming Platforms
11. New investment fund will advance late-stage vaccines, other global health technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2019)... ... January 03, 2019 , ... Over the last ... their drug discovery research workflows with biology ranging from single cell-type spheroids to ... in vitro studies, they create several challenges that need to be overcome in ...
(Date:12/25/2018)... , ... December 24, 2018 , ... ... The Rockefeller University have discovered a new use for a long-standing computational concept ... spam control, blocking unwanted files and messages. Using blacklisting as a filter to ...
(Date:12/19/2018)... ... , ... InTouchMD’s flagship product, Pulse , has been honored by PM360 ... is featuring the recognition in its 7th annual Innovations issue, created for purpose of ... medical device industries. , “This recognition comes at an exciting time for Pulse as ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. ... Disease drug candidate, code-named "KM-819." KM-819 is an orally active small molecule ... in South Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study ...
(Date:12/20/2018)... ... , ... New Year’s brings reflection and desire to improve for individuals and ... (EU) on the horizon, Jim Kasic, president and CEO of Boulder iQ, suggests five ... Device Regulation (MDR), digital health, and big data are just a few of the ...
(Date:12/18/2018)... ... ... Patients with early stages of breast cancer who undergo partial breast proton ... irradiation, a new study suggests. , Patients with early stage breast cancer — stage ... the cancerous tumor because there is a 30 to 40 percent change the disease ...
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial ... (human) ingredient. This has been part of their strategic plan and an important ... certification creates custom fermentation opportunities for MDG within the $44 Billion human probiotic ...
Breaking Biology Technology: